Ubicom Holdings. Inc. · TSE:3937
Ubicom — Q2 2022 Earnings Presentation
30 slides from Ubicom's earnings presentation, Nov 10, 2022
Slide 1: Presentation Materials for FY2022 Q2
FY2022 Q2 Consolidated Business Results Presentation Materials for FY2022 Q2 Ubicom Holdings, Inc. TSE Prime: 3937 November 10, 2022 Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and th
Slide 2: FY2022 Q2 Highlights
FY2022 Q2 Highlights Hit “record highs” in operating and ordinary income for the first half of the fiscal year, while making investments for the second growth phase. Net Sales 2,602 million yen Ordinary Income 494 million yen （ 114.7％ year-on-year) （103.5％ year-on-year） Operating Income 501 million
Slide 3: FY2022 Q2 (P/L)
FY2022 Q2 (P/L) Our company has been able to secure solid growth in net sales, operating income and ordinary income on a first half cumulative basis, owing to continued strong demand for development and solutions since the second half of the previous fiscal year, the promotion of measures to cope wi
Slide 4: FY2022 1st Half Investment in Human Resources and Exchange Rate Measures
FY2022 1st Half Situation of Investment in Human Resources, and Measures on the Effects of Exchange Rates Situation of investment in human resources, including recruitment We kept making continuous human resource investments. Aggressive new graduate recruiting and training program “ACTION” commenc
Slide 5: FY2022 1st Half Investment Status
FY2022 1st Half Investment Status Investments (already factored into full-year plan) made mainly in Q2 to promote the second growth phase. Business expansion is expected from the second half of this fiscal year onwards. Investment External Effects during Measures the current scale environment term D
Slide 6: FY2022 1st Half Purpose of Investment Enhancement
FY2022 1st Half Purpose of Investment Enhancement We have begun to enhance development resources, mainly for our global business, as the cornerstone for our group's overall medium/long-term growth strategy. Target Market Size (Our calculations) 20 billion yen 50 billion yen 20 billion yen 10 billion
Slide 7: FY2022 Q2 Overview of Each Segment: Global Business
FY2022 Q2 Overview of Each Segment: Global Business Continued to increase profits by more than 20% year-on-year, taking into account investments for the second growth phase FY2021 FY2022 Global Business Year-on- Q2 Q2 % to Year (unit: million yen) Amount % to sales Amount sales Net Sales 1,528 100.0
Slide 8: Global Business Strategy: Progress in Sales Currency Portfolio
Global Business Strategy: Progress in Sales Currency Portfolio Promoting diversification of sales currency portfolio to strengthen financial resilience against foreign exchange risks. Foreign currency-denominated settlements are expected to exceed 40% in the second half of current FY 2022 ahead of s
Slide 9: Global Business Strategy: Progress in Applying New Unit Prices
Global Business Strategy: Progress in Applying New Unit Prices In anticipation of increasing global demand for IT personnel, especially advanced AI personnel, we have made steady progress in shifting to a high unit-price model from the current fiscal year. Enhancement of high-level human resources :
Slide 10: Global Business: Change and Outlook of Sales Composition by Strategic Field
Global Business: Change and Outlook of Sales Composition by Strategic Field We aim to expand the AI-related business by developing cutting-edge personnel. We will concentrate on the increase of orders received in the AI field toward FY2024. © Ubicom Holdings, Inc. 10
Slide 11: Global Business: Promote “GO GLOBAL” Strategy
Global Business: Promote “GO GLOBAL” Strategy To strengthen business strategies with an eye on the global market (1) Promote global M&A, investment and business alliances (2) Strengthen overseas marketing (U.S./Israel) (3) AI education through alliances with companies in digitally advanced countries
Slide 12: Global Business: Advancement of Business Model
Global Business: Advancement of Business Model Generate pillar clients and high profitability through flexible offshore/onsite development Definition of pillar clients: Constant clients that are market leaders in each field with sales scale of several 100 million yen Establishment of Offshore (our d
Slide 13: Overview of Each Segment in FY 2022 Q2: Medical Business
Overview of Each Segment in FY 2022 Q2: Medical Business Ensured strong profitability and a consistent trend of profit growth. Medical Business FY2021 FY2022 Q2 Q2 Year-on- % to Year (unit: million yen) Amount % to sales Amount sales Net Sales 740 100.0% 756 100.0% 102.2% Operating Income 399 53.9%
Slide 14: Medical Business: Advancement of Business Model
Medical Business: Advancement of Business Model Expansion of highly profitable foundation with the subscription model Trend of Medical Business Performance Sales Composition Trend of Medical Business (unit: million yen) *recurring ratio: continuous sales ratio © Ubicom Holdings, Inc. 14
Slide 15: Medical Business: External Environment and Promotion of Business Strategy
Medical Business: External Environment and Promotion of Business Strategy Marketing of medical solution/platform concept in line with medical healthcare DX policy to began in this FY 2022 Q2 ■External environment surrounding the medical business: Priority Areas from FY 2022 Q3 Administrative Medical
Slide 16: Medical Business: To Strengthen Sales Strategy
Medical Business: To Strengthen Sales Strategy Strengthening strategy to promote sales of the Mighty series Priority measures for the second half of FY 2022 and beyond ... direct sales/consulting Sales enhancements Feedback Customer Support ... building a user community ... strengthening cost-effect
Slide 17: Medical Business: Started Receiving Pre-orders for the New Mighty QUBE
Medical Business: Started Receiving Pre-orders for the New Mighty QUBE Favorable volume of pre-orders ahead of the official launch. Several public hospitals have already installed the system in this FY 2022 Q2. Features of the new Mighty QUBE Compatible with Doctor Workstyle Reform 2024 Hybrid m
Slide 18: Medical Business: Effects of Mainstay Solutions
Medical Business: Effects of Mainstay Solutions ■Effects of Mighty Checker (MC) for Medical Affairs *1 (1) Reduction of operation time (2) Cost reduction and profit improvement Conventional medical claims inspection Inspection (Visual) of medical claims after introducing MC Inspection cost 100% Redu
Slide 19: Progress of Insurance Knowledge Platform
Progress of Insurance Knowledge Platform ■Progress of opportunities under negotiation ・Negotiations are underway with a total of 7 out of approx. 50 companies in the life insurance market ➡out of which, 3 companies are in the process of PoC verification for installation in FY2022 ➡2 semi-major compa
Slide 20: Medical Domain: Growth Potential of each Solution
Medical Domain: Growth Potential of each Solution To promote further improvement of average spending per customer and recurring revenue earning capability through up-selling, cross-selling, and direct sales New Medical Platform Insurance Knowledge Platform SonaM Mighty QUBE + New MQ GP margin of Mig
Slide 21: Target Market Size for Medical Platforms
Target Market Size for Medical Platforms We aim to become the No. 1 platform in the niche medical field by leveraging our position as the market leader in DX solutions focused on medical institutions. New (domestic and overseas) Insurance Strategic Medical companies Markets institutions Insurance Kn
Slide 22: Medical Platform Utilization Strategy (Medium/Long-term Vision)
Medical Platform Utilization Strategy (Medium/Long-term Vision) To create more new markets through strategies to enclose the user community (potential market size: 300 billion yen*) *surveyed by our company ・Conversion of sales staff to consultants New market ・Medical engineer training Creation ・Str
Slide 23: Promotion of M&A Strategy Based on Results of Acquisition of Subsidiaries
Promotion of M&A strategy based on the results of acquisition of subsidiaries We aim to actualize new M&A that would contribute to our platformer strategy, by utilizing the know-how of post-merger integration (PMI) for medical business. ■Successful cases of M&A: Variation in results of medical busin
Slide 24: FY2022 Priority Measures
FY2022 Priority measures While paying attention to the profit balance, we will take measures for fortifying the base for the second growth phase. 1. To enrich expert resources that would contribute to “Go Global Strategy” 2. To enhance the recruitment and training of Filipino engineers 3. To beef up
Slide 25: ESG: Towards Sustainable Development of Business, Society & Customer
ESG: Towards Sustainable Development of Business, Society & Customer ■Global Business ・DX Support (Business process reforms for clients through advanced technology support such as AI/Analytics/Automation/Cloud) ・Improvement of Japan’s global competitiveness through globalization support for domestic
Slide 26: Promotion of the Group Business Based on Social Meanings
Promotion of the group business based on social meanings Entire group Medical business Resilient management, Provision of solutions that are beneficial personnel development strategy, to all parties as they contribute to the business synergy, and pursuit of reform of doctors’ workstyles, the signifi
Slide 27: Promotion of the Leverage Strategy (the 2nd Growth Phase)
Promotion of the Leverage Strategy (the 2nd Growth Phase) To maximize the synergy between the existing business and M&A, and promote the development of new recurring-revenue/SaaS model ・Medical field Themes of the ・Pillar clients: + 20 companies ・Global market ×M&A second growth phase ・Sustainabilit
Slide 28: Company Overview
Company Overview ■Company name: Ubicom Holdings, Inc. (TSE Prime: 3937) ■Strategic industry: Medical, Financial/Public, Automotive, Manufacturing/Robotics, etc. ■Our Business: Global Business Dedicated in solving IT resource shortage in Japan and promoting DX (Digital Transformation), through provid
Slide 29: Cautionary Note on Forward Looking Statements
Cautionary Note on Forward Looking Statements This material may contain forward looking statements and forecasts regarding the future outlook at the time of publication. They are subject to risks and uncertainties including, but not limited to, domestic and international economic conditions such
Slide 30: © Ubicom Holdings, Inc.
© Ubicom Holdings, Inc.